request the Commissioner of the Food and Drug Administration to declare that the drug product Cefixime for Oral Suspension, 200 mg/mL, is suitable for submission as an ANDA-CLOSED
🏛 Food and Drug Administration (FDA)FDA-2005-P-0265
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
OtherApr 25, 2005
Petition Approval from FDA CDER to Lupin Pharmaceuticals, Inc.- Other· Jan 13, 2005